Human Milk Oligosaccharides: What They Are and Why They Matter

Human milk oligosaccharides — HMOs — are among the most fascinating and least understood components of breast milk. Here's what they are, what they do, and why they're relevant in an adult nursing context.

What HMOs Are

Human milk oligosaccharides are complex carbohydrates — the third most abundant solid component of breast milk after fat and lactose. There are over 200 structurally distinct HMOs in human milk, and the profile varies between individuals, changes over the course of lactation, and differs between colostrum and mature milk.

Unlike lactose and fat, HMOs are not digested by the person consuming them in the conventional sense. They pass largely intact through the stomach and small intestine to reach the colon, where they function primarily as prebiotics — selectively feeding beneficial bacteria, particularly Bifidobacterium species, which dominate the gut microbiome of breastfed infants.

What They Do in Infants

The role of HMOs in infant health is the subject of extensive research and significant commercial interest — HMO synthesis is now a major focus for infant formula manufacturers. In infants, HMOs support the development of the gut microbiome, provide prebiotic support for immune development, act as decoy receptors that prevent pathogens from adhering to gut epithelial cells, and may have direct effects on brain development.

This is well-established science. The infant-focused research is robust.

What They Do in Adults — The Honest Picture

Here the evidence is thinner and requires more caution.

Adults have a fully developed gut microbiome and digestive system that is quite different from a newborn's. The specific Bifidobacterium species that HMOs so efficiently feed in infants are less dominant in adult guts. Whether HMOs have similar prebiotic effects in adults, and whether those effects are clinically meaningful, is genuinely uncertain.

Some research suggests that certain HMOs have anti-inflammatory properties, potential effects on gut barrier function, and possible immune-modulating effects that could be relevant in adults. 2'-fucosyllactose (2'-FL), one of the most abundant HMOs, is being studied for applications in adult gastrointestinal conditions. But this research is early-stage.

The honest summary: HMOs are biologically active compounds that are not inert in adults. Whether the amounts present in breast milk consumed in the context of ANR are sufficient to produce measurable health effects in adults is unknown. The claim that HMOs provide significant health benefits to adult nursing partners exists ahead of the evidence.

Why This Matters for the ANR Community

HMOs have become a talking point in some ANR-adjacent content as part of a broader argument for the "health benefits" of adult breast milk consumption. Some of these claims are reasonable; others significantly overstate what the evidence supports.

Being accurate about this matters. The value of ANR — the bonding, the intimacy, the hormonal environment, the particular quality of the nursing relationship — doesn't depend on breast milk being a health supplement. Overstating the science invites scrutiny that can undermine the credibility of more solid claims.

What we can say: human breast milk is a nutritionally and biologically complex fluid. HMOs are a fascinating component of it. The science on their effects in adults is genuinely interesting and developing. The appropriate response to emerging science is curiosity rather than premature certainty in either direction.